Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Methodol. Jun 26, 2014; 4(2): 91-98
Published online Jun 26, 2014. doi: 10.5662/wjm.v4.i2.91
Published online Jun 26, 2014. doi: 10.5662/wjm.v4.i2.91
New prospects in the diagnosis and treatment of immune-mediated inner ear disease
David R Lobo, Department of Otolaryngology, Hospital El Escorial, San Lorenzo de El Escorial, 28200 Madrid, Spain
David R Lobo, Instituto Antolí-Candela, 28043 Madrid, Spain
Jose Ramon García-Berrocal, Rafael Ramírez-Camacho, Department of Otorhinolaryngology, Hospital Puerta de Hierro, Majadahonda, 28222 Madrid, Spain
Author contributions: Lobo DR, García-Berrocal JR and Ramirez-Camacho R solely contributed to this paper.
Correspondence to: David R Lobo, MD, PhD, Department of Otolaryngology, Hospital E Escorial, Carretera Guadarrama s/n, San Lorenzo de El Escorial, 28200 Madrid, Spain. dlobo28@gmail.com
Telephone: +34-918-973021 Fax: +34-918-973031
Received: November 26, 2013
Revised: February 10, 2014
Accepted: April 11, 2014
Published online: June 26, 2014
Revised: February 10, 2014
Accepted: April 11, 2014
Published online: June 26, 2014
Core Tip
Core tip: Readers interested in inner ear pathology will find in this review a brief summary of autoimmune inner ear disease, with special focus on the major advances achieved in the knowledge of its etiology and pathophysiology, and the diagnostic and therapeutic challenges that remain and may guide research in the next few years and beyond.